Adam Rogers
Directeur/Membre du Conseil chez NERVGEN PHARMA CORP.
Fortune : 15 000 $ au 30/04/2024
Postes actifs de Adam Rogers
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NERVGEN PHARMA CORP. | Directeur/Membre du Conseil | 14/07/2022 | - |
| President | 22/09/2022 | 10/04/2023 | |
Hemera Biosciences, Inc.
 Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Directeur Général | 01/01/2017 | - |
| Fondateur | 01/01/2010 | - | |
| President | 01/01/2010 | 01/01/2017 | |
| One Family, Inc. | Directeur/Membre du Conseil | 01/01/2007 | - |
Historique de carrière de Adam Rogers
Anciens postes connus de Adam Rogers
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Emory University School of Medicine | Corporate Officer/Principal | - | 02/01/1991 |
Formation de Adam Rogers
| Emory University School of Medicine | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Canada | 2 |
Opérationnelle
| President | 2 |
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NERVGEN PHARMA CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Hemera Biosciences, Inc.
Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Health Technology |
| One Family, Inc. |
- Bourse
- Insiders
- Adam Rogers
- Expérience
